118 related articles for article (PubMed ID: 34057866)
1. Anti-tumor effect of M2000 (β-d-mannuronic acid) on the expression of inflammatory molecules in the prostate cancer cell.
Mohsenzadegan M; Moghbeli F; Mirshafiey A; Farajollahi MM
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):419-430. PubMed ID: 34057866
[No Abstract] [Full Text] [Related]
2. The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line.
Sharifi L; Moshiri M; Dallal MMS; Asgardoon MH; Nourizadeh M; Bokaie S; Mirshafiey A
Recent Pat Inflamm Allergy Drug Discov; 2019; 13(1):57-65. PubMed ID: 30539708
[TBL] [Abstract][Full Text] [Related]
3. The Anti-tumoral Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGFβ1 Gene Expression in Pre-surgical Breast Cancer Patients.
Kashefi S; Ahmadi H; Omranipour R; Mahmoodzadeh H; Jafarnezhad-Ansariha F; Tofighi Zavareh F; Mirshafiey A
Iran J Allergy Asthma Immunol; 2019 Feb; 18(1):80-90. PubMed ID: 30848576
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of β-D-Mannuronic Acid [M2000] on the Pro-Apoptotic Process and Inflammatory-Related Molecules NFκB, IL-8 and Cd49d using Healthy Donor PBMC.
Khalatbari A; Mahdavi M; Jafarnezhad F; Afraei S; Zavareh FT; Aghazadeh Z; Ghaderi A; Mirshafiey A
Curr Drug Discov Technol; 2020; 17(2):225-232. PubMed ID: 30417790
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of β-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-κB gene expression, as target molecules in inflammatory reactions.
Mortazavi-Jahromi SS; Jamshidi MM; Farazmand A; Aghazadeh Z; Yousefi M; Mirshafiey A
Pharmacol Rep; 2017 Jun; 69(3):479-484. PubMed ID: 28324845
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Mannuronic Acid Effect on Gene Expression Profile of Inflammatory Mediators in Rheumatoid Arthritis Patients.
Omidian S; Aghazadeh Z; Ahmadzadeh A; Aslani M; Hosseini M; Abbasi S; Mirshafiey A
Iran J Allergy Asthma Immunol; 2022 Feb; 21(1):44-54. PubMed ID: 35524377
[TBL] [Abstract][Full Text] [Related]
7. The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.
Jafarnezhad-Ansariha F; Yekaninejad MS; Jamshidi AR; Mansouri R; Vojdanian M; Mahmoudi M; Fattahi MJ; Hashemi SN; Rehm BHA; Matsuo H; Esposito E; Cuzzocrea S; Mirshafiey A
Inflammopharmacology; 2018 Apr; 26(2):375-384. PubMed ID: 28819782
[TBL] [Abstract][Full Text] [Related]
8. Influence of β-D-mannuronic Acid, as a New Member of Non-steroidal Anti- Inflammatory Drugs Family, on the Expression Pattern of Chemokines and their Receptors in Rheumatoid Arthritis.
Aslani M; Ahmadzadeh A; Aghazadeh Z; Zaki-Dizaji M; Sharifi L; Hosseini M; Mirshafiey A
Curr Drug Discov Technol; 2021; 18(1):65-74. PubMed ID: 31657689
[TBL] [Abstract][Full Text] [Related]
9. The Oral Administration Effect of Drug Mannuronic Acid (M2000) on Gene Expression of Matrix and Tissue Inhibitor of Metalloproteinases in Rheumatoid Arthritis Patients.
Gaafar NAG; Aslani M; Aghazadeh Z; Razavi A; Mirshafiey A
Curr Drug Discov Technol; 2020; 17(5):704-710. PubMed ID: 31250758
[TBL] [Abstract][Full Text] [Related]
10. Hematological Improvement of Patients with Active Rheumatoid Arthritis by β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property.
Ahmadi H; Jamshidi AR; Mahmoudi M; Gharibdoost F; Vojdanian M; Fattahi MJ; Rastkari N; Aghazadeh Z; Mirshafiey A
Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):433-442. PubMed ID: 29149783
[TBL] [Abstract][Full Text] [Related]
11. The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients.
Mortazavi-Jahromi SS; Ahmadzadeh A; Rezaieyazdi Z; Aslani M; Omidian S; Mirshafiey A
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):228-236. PubMed ID: 32223462
[No Abstract] [Full Text] [Related]
12. Anti-inflammatory Property of β-D-Mannuronic Acid (M2000) on Expression and Activity of Matrix Metalloproteinase-2 and -9 through CD147 Molecule in Phorbol Myristate Acetate-differentiated THP-1 Cells.
M Farahani M; Motevaseli E; Maghsood F; Heidari-Kharaji M; Mirshafiey A
Iran J Allergy Asthma Immunol; 2017 Oct; 16(5):443-451. PubMed ID: 29149784
[TBL] [Abstract][Full Text] [Related]
13. The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients.
Roozbehkia M; Mahmoudi M; Aletaha S; Rezaei N; Fattahi MJ; Jafarnezhad-Ansariha F; Barati A; Mirshafiey A
Int Immunopharmacol; 2017 Nov; 52():191-196. PubMed ID: 28938189
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenesis effect of β-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive properties under experimental model.
Rastegari-Pouyani M; Mostafaie A; Mansouri K; Mortazavi-Jahromi SS; Mohammadi-Motlagh HR; Mirshafiey A
Clin Exp Pharmacol Physiol; 2018 Apr; 45(4):370-376. PubMed ID: 29266560
[TBL] [Abstract][Full Text] [Related]
15. Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients.
Mortazavi-Jahromi SS; Aslani M; Omidian S; Ahmadzadeh A; Rezaieyazdi Z; Mirshafiey A
Drug Dev Res; 2020 May; 81(3):295-304. PubMed ID: 31675124
[TBL] [Abstract][Full Text] [Related]
16. Targeting of circulating Th17 cells by β-D-mannuronic acid (M2000) as a novel medication in patients with rheumatoid arthritis.
Ahmadi H; Mahmoudi M; Gharibdoost F; Vojdanian M; Jamshidi AR; Fattahi MJ; Aghazadeh Z; Barati A; Mirshafiey A
Inflammopharmacology; 2018 Feb; 26(1):57-65. PubMed ID: 29063487
[TBL] [Abstract][Full Text] [Related]
17. Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.
Mirshafiey A; Cuzzocrea S; Rehm B; Mazzon E; Saadat F; Sotoude M
Scand J Immunol; 2005 May; 61(5):435-41. PubMed ID: 15882435
[TBL] [Abstract][Full Text] [Related]
18. Introduction of β-d-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1/COX-2 activity and gene expression.
Mirshafiey A; Taeb M; Mortazavi-Jahromi SS; Jafarnezhad-Ansariha F; Rehm BHA; Esposito E; Cuzzocrea S; Matsuo H
Pharmacol Rep; 2017 Oct; 69(5):1067-1072. PubMed ID: 28951072
[TBL] [Abstract][Full Text] [Related]
19. M2000 (β-D-Mannuronic Acid) as a Novel Antagonist for Blocking the TLR2 and TLR4 Downstream Signalling Pathway.
Aletaha S; Haddad L; Roozbehkia M; Bigdeli R; Asgary V; Mahmoudi M; Mirshafiey A
Scand J Immunol; 2017 Feb; 85(2):122-129. PubMed ID: 27943385
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory effects of M2000 (β-D-Mannuronic acid) on TNF-α, IL-17 and FOXP3 gene expression in patients with inflammatory bowel disease.
Mohammed HA; Saboor-Yaraghi AA; Vahedi H; Yekaninejad MS; Panahi G; Hemmasi G; Lakzaei M; Mirshafiey A
Int Immunopharmacol; 2017 Oct; 51():107-113. PubMed ID: 28822915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
